Literature DB >> 23791140

Escitalopram and QTc prolongation.

Mehrul Hasnain, Robert H Howland, W Victor R Vieweg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23791140      PMCID： PMC3692726          DOI： 10.1503/jpn.130055

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  3 in total

1.  A critical evaluation of the cardiac toxicity of citalopram: part 1.

Authors:  Robert H Howland
Journal:  J Psychosoc Nurs Ment Health Serv       Date:  2011-10-19       Impact factor: 1.098

2.  Antidepressants and QTc prolongation.

Authors:  Raymond W Lam
Journal:  J Psychiatry Neurosci       Date:  2013-03       Impact factor: 6.186

Review 3.  Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling?

Authors:  W Victor R Vieweg; Mehrul Hasnain; Robert H Howland; John M Hettema; Christopher Kogut; Mark A Wood; Ananda K Pandurangi
Journal:  Am J Med       Date:  2012-06-27       Impact factor: 4.965
  3 in total
  8 in total

1.  Author response.

Authors:  Raymond W Lam
Journal:  J Psychiatry Neurosci       Date:  2013-07       Impact factor: 6.186

2.  Escitalopram population pharmacokinetics in people living with human immunodeficiency virus and in the psychiatric population: Drug-drug interactions and probability of target attainment.

Authors:  Perrine Courlet; Monia Guidi; Anaïs Glatard; Susana Alves Saldanha; Matthias Cavassini; Thierry Buclin; Catia Marzolini; Chin B Eap; Laurent A Decosterd; Chantal Csajka
Journal:  Br J Clin Pharmacol       Date:  2019-07-07       Impact factor: 4.335

3.  Implementation of warnings from Dear Doctor Letters (Rote-Hand-Briefe): an analysis of medication data from a large cohort of elderly patients.

Authors:  Simone Schächtele; Thomas Tümena; Karl-Günter Gaßmann; Martin F Fromm; Renke Maas
Journal:  Dtsch Arztebl Int       Date:  2014-04-11       Impact factor: 5.594

4.  Specialty knowledge and competency standards for pharmacotherapy for adult obsessive-compulsive disorder.

Authors:  Christopher Pittenger; Brian P Brennan; Lorrin Koran; Carol A Mathews; Gerald Nestadt; Michele Pato; Katharine A Phillips; Carolyn I Rodriguez; H Blair Simpson; Petros Skapinakis; Dan J Stein; Eric A Storch
Journal:  Psychiatry Res       Date:  2021-03-04       Impact factor: 11.225

Review 5.  Management of Dementia-Related Psychosis, Agitation and Aggression: A Review of the Pharmacology and Clinical Effects of Potential Drug Candidates.

Authors:  Monika Marcinkowska; Joanna Śniecikowska; Nikola Fajkis; Paweł Paśko; Weronika Franczyk; Marcin Kołaczkowski
Journal:  CNS Drugs       Date:  2020-03       Impact factor: 5.749

6.  Effect of proton pump inhibitors on the serum concentrations of the selective serotonin reuptake inhibitors citalopram, escitalopram, and sertraline.

Authors:  Caroline Gjestad; Andreas A Westin; Eirik Skogvoll; Olav Spigset
Journal:  Ther Drug Monit       Date:  2015-02       Impact factor: 3.681

7.  Psychotropic Drugs and Prolonged QTc Interval: Does it Really that Matter?

Authors:  Ahmed Naguy
Journal:  Indian J Psychol Med       Date:  2016 Mar-Apr

8.  Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials.

Authors:  Natasha Chawla; Thunyarat Anothaisintawee; Kridsada Charoenrungrueangchai; Papan Thaipisuttikul; Gareth J McKay; John Attia; Ammarin Thakkinstian
Journal:  BMJ       Date:  2022-01-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.